Biomarker and Drug Target Validation
A portfolio of Molecular Methods for validating biomarkers and drug targets
Once identified, biomarkers and potential drug targets need to be validated, e.g. to confirm the efficiency of a given drug candidate against its target or to confirm the differential expression of a given biomarker to report a specific disease condition or a cellular state. For this purpose Bioneer offers many different opportunities depending on the character of the molecule in question:
- In situ visualization: FISH, CISH, IHC and combinations thereof
- Quantitative PCR targeting mRNA, ncRNA and miRNA
- Traditional Northern and Western blotting methodology
For further information, please contact Group Leader, Biomarkers; Kim Holmstroem by phone (+45 45160444) or email.